EF Hutton Initiates Coverage On Artelo Biosciences with Buy Rating, Announces Price Target of $6
Portfolio Pulse from Benzinga Newsdesk
EF Hutton has initiated coverage on Artelo Biosciences with a Buy rating and set a price target of $6.
October 01, 2024 | 1:03 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
EF Hutton has initiated coverage on Artelo Biosciences with a Buy rating and a price target of $6, indicating a positive outlook for the stock.
The initiation of coverage with a Buy rating and a specific price target of $6 by EF Hutton suggests a positive sentiment towards Artelo Biosciences. This is likely to attract investor interest and potentially drive the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100